May 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 7.26 billion in 2025 with a CAGR of 15.17%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
June 2025
The global viral vectors for non human primates market size is estimated to hit around USD 397.87 million by 2034 from USD 145.8 million in 2024, at a CAGR of 10.56%.
June 2026
The U.S. viral vectors and plasmid DNA manufacturing market size was evaluated at USD 2.84 billion in 2025 and is predicted to hit around USD 11.69 billion by 2035, growing at a CAGR of 15.20%.
May 2026
The global viral and non-viral vectors market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 48.37 billion by 2035, growing at a CAGR of 17.80%.
May 2026
The global DNA-based non-viral technologies market size was evaluated at USD 5.60 billion in 2025 and is predicted to hit around USD 27.85 billion by 2035, growing at a CAGR of 17.40%.
January 2026
The viral clearance market size was estimated at USD 1.13 billion in 2025 and is expected to attain around USD 7.86 billion by 2035, with a CAGR of 21.40%.
September 2025
The antiviral and antimicrobial technology market is growing with demand for advanced coatings, textiles, and surfaces that prevent infection and contamination.
July 2025
The bacterial and viral specimen collection market size is predicted to surge around USD 168.63 billion by 2034 from USD 52.52 billion in 2025 with a CAGR of 13.87%.
July 2025
The global respiratory antiviral treatment market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2034.
January 2025
The global lentiviral vector market size is projected to surpass around USD 1,908.19 million by 2034 increasing from USD 348.61 million in 2024, with a CAGR of 18.53%.
July 2025
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com